Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke
- Authors
- Takeyama K.; Jung B.; Shim J.J.; Burgel P.-R.; Dao-Pick T.; Ueki I.F.; Protin U.; Kroschel P.; Nadel J.A.
- Issue Date
- 2001
- Keywords
- Airway epithelial differentiation; Human goblet factor
- Citation
- American Journal of Physiology - Lung Cellular and Molecular Physiology, v.280, no.1 24-1, pp L165 - L172
- Indexed
- SCOPUS
- Journal Title
- American Journal of Physiology - Lung Cellular and Molecular Physiology
- Volume
- 280
- Number
- 1 24-1
- Start Page
- L165
- End Page
- L172
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/22869
- ISSN
- 1040-0605
1522-1504
- Abstract
- Mucus hypersecretion from hyperplastic airway goblet cells is a hallmark of chronic obstructive pulmonary disease (COPD). Although cigarette smoking is thought to be involved in mucus hypersecretion in COPD, the mechanism by which cigarette smoke induces mucus overproduction is unknown. Here we show that activation of epidermal growth factor receptors (EGFR) is responsible for mucin production after inhalation of cigarette smoke in airways in vitro and in vivo. In the airway epithelial cell line NCI-H292, exposure to cigarette smoke upregulated the EGFR mRNA expression and induced activation of EGFR-specific tyrosine phosphorylation, resulting in upregulation of MUC5AC mRNA and protein production, effects that were inhibited completely by selective EGFR tyrosine kinase inhibitors (BIBX1522, AG-1478) and that were decreased by antioxidants. In vivo, cigarette smoke inhalation increased MUC5AC mRNA and goblet cell production in rat airways, effects that were prevented by pretreatment with BIBX1522. These effects may explain the goblet cell hyperplasia that occurs in COPD and may provide a novel strategy for therapy in airway hypersecretory diseases.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Pulmonary, Allergy, and Critical Care Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.